All 33 PBE (INVESCO BIOTECHNOLOGY & GENOME ETF) Holdings
There are 33 PBE holdings. Top 10 companies weight: 44.62%.
Total Market Cap: $833B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (33 stocks) | +27.67% | 22.69 | 18.58 | 0.57 | +14.31% | +10.89% | 0.53 | ||||||||||
1 | VRTX | Vertex Pharmaceuticals Inc | 5.35% | $480.50 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.39% | $554 | +19.61% | 0.49 |
2 | BIIB | Biogen Inc | 4.95% | $199.95 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +13.17% | $226 | -9.14% | 0.51 |
3 | AMGN | Amgen Inc | 4.92% | $364.17 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.07% | $357 | +11.73% | 0.46 |
4 | RPRX | Royalty Pharma Plc Class A | 4.74% | $57.30 | $25B | Biotechnology | Healthcare | N/A | 28.69 | 48.08 | 1.32 | N/A | N/A | 75 | +4.53% | $60 | +9.29% | 0.25 |
5 | ALNY | Alnylam Pharmaceuticals Inc | 4.68% | $272.67 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +59.47% | $435 | +8.65% | 0.81 |
6 | REGN | Regeneron Pharmaceuticals Inc | 4.56% | $672.15 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.87% | $819 | +3.03% | 0.60 |
7 | GILD | Gilead Sciences Inc | 4.34% | $133.21 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +18.83% | $158 | +18.49% | 0.35 |
8 | UTHR | United Therapeutics Corp | 4.25% | $529.34 | $22B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 17.96 | 19.49 | 1.91 | N/A | N/A | 75 | +25.34% | $663 | +23.70% | 0.41 |
9 | TECH | Bio-techne Corp | 3.56% | $71.64 | $11B | Biotechnology | Healthcare | -10.07% | 101.96 | 34.48 | 0.96 | N/A | N/A | 58 | -2.29% | $70 | -8.73% | 1.13 |
10 | CDNA | Caredx Inc | 3.27% | $38.37 | $1.53B | Diagnostics & Research | Healthcare | -10.97% | N/A | 94.34 | N/A | N/A | N/A | 60 | -14.00% | $33 | -14.62% | 1.27 |
11 | VCEL | Vericel Corp | 3.24% | $45.88 | $2.38B | Biotechnology | Healthcare | +35.66% | 109.92 | 98.04 | 0.18 | N/A | N/A | 71 | +24.54% | $57 | -3.35% | 1.13 |
12 | PTGX | Protagonist Therapeutics Inc | 3.17% | $134.27 | $8.70B | Biotechnology | Healthcare | +1.43% | N/A | 29.85 | N/A | N/A | N/A | 78 | -6.79% | $125 | +22.86% | 0.21 |
13 | ILMN | Illumina Inc | 3.13% | $184.68 | $29B | Diagnostics & Research | Healthcare | -6.80% | 44.12 | 35.59 | 3.34 | N/A | N/A | 60 | -9.23% | $168 | -16.96% | 1.00 |
14 | VCYT | Veracyte Inc | 3.11% | $57.26 | $4.75B | Diagnostics & Research | Healthcare | N/A | 53.71 | 34.36 | 0.34 | N/A | N/A | 70 | -1.24% | $57 | +8.04% | 1.36 |
15 | RGEN | Repligen Corp | 2.98% | $145.49 | $8.35B | Medical Instruments & Supplies | Healthcare | +9.09% | 162.20 | 74.63 | 0.62 | N/A | N/A | 75 | +22.38% | $178 | -6.50% | 1.32 |
16 | PTCT | Ptc Therapeutics Inc | 2.97% | $78.01 | $6.53B | Biotechnology | Healthcare | -16.59% | N/A | 56.82 | 0.81 | N/A | N/A | 75 | +22.97% | $96 | +12.92% | 0.99 |
17 | ACAD | Acadia Pharmaceuticals Inc | 2.94% | $25.09 | $4.43B | Biotechnology | Healthcare | N/A | 11.73 | 76.34 | 0.19 | N/A | N/A | 72 | +30.13% | $33 | +1.12% | 0.90 |
18 | INCY | Incyte Corp | 2.90% | $115.65 | $23B | Biotechnology | Healthcare | +27.16% | 15.82 | 15.06 | N/A | N/A | N/A | 61 | -1.58% | $114 | +7.88% | 0.57 |
19 | BCRX | Biocryst Pharmaceuticals Inc | 2.80% | $9.11 | $2.39B | Drug Manufacturers - Specialty & Generic | Healthcare | +6.24% | N/A | 86.96 | N/A | N/A | N/A | 82 | +130.52% | $21 | -11.23% | 0.77 |
20 | HALO | Halozyme Therapeutics Inc | 2.79% | $77.09 | $8.99B | Biotechnology | Healthcare | +20.06% | 25.62 | 10.78 | N/A | N/A | N/A | 67 | +8.83% | $84 | +12.87% | 0.62 |
21 | SRPT | Sarepta Therapeutics Inc | 2.79% | $16.83 | $1.86B | Biotechnology | Healthcare | N/A | 4.88 | 5.01 | 159.25 | N/A | N/A | 48 | +31.73% | $22 | -24.47% | 1.40 |
22 | QGEN | Qiagen Nv | 2.72% | $40.48 | $8.51B | Diagnostics & Research | Healthcare | +3.15% | 20.03 | 12.94 | 0.05 | N/A | N/A | 70 | +8.87% | $44 | -4.19% | 0.50 |
23 | NBIX | Neurocrine Biosciences Inc | 2.70% | $173 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +15.75% | $200 | +12.11% | 0.79 |
24 | EXEL | Exelixis Inc | 2.69% | $55.53 | $14B | Biotechnology | Healthcare | +72.24% | 17.54 | 17.70 | 0.45 | N/A | N/A | 59 | -8.28% | $51 | +26.67% | 0.52 |
25 | BMRN | Biomarin Pharmaceutical Inc | 2.69% | $59.11 | $11B | Biotechnology | Healthcare | -20.33% | 42.21 | 11.96 | 0.73 | N/A | N/A | 75 | +48.81% | $88 | -5.79% | 0.65 |
26 | ANAB | Anaptysbio Inc | 2.65% | $50.29 | $1.62B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 81 | +73.18% | $87 | +23.70% | 0.80 |
27 | COLL | Collegium Pharmaceutical Inc | 2.64% | $35.54 | $1.19B | Drug Manufacturers - Specialty & Generic | Healthcare | -5.45% | 40.29 | 4.86 | N/A | N/A | N/A | 79 | +50.82% | $54 | +6.96% | 0.50 |
28 | LEGN | Legend Biotech Corp Adr | 2.44% | $23.21 | $4.26B | Biotechnology | Healthcare | -13.49% | N/A | 149.25 | N/A | N/A | N/A | 80 | +139.68% | $56 | -13.38% | 0.49 |
29 | ARDX | Ardelyx Inc | 2.03% | $5.09 | $1.31B | Biotechnology | Healthcare | -26.76% | N/A | 40.65 | N/A | N/A | N/A | 77 | +220.24% | $16 | +21.47% | 0.79 |
30 | OMER | Omeros Corp | 1.92% | $9.63 | $747M | Biotechnology | Healthcare | N/A | 9.26 | 58.14 | 0.81 | N/A | N/A | 58 | +242.68% | $33 | -7.69% | 1.37 |
31 | AGPXX | Invesco Shrt-trm Inv Gov&agcy Instl | 0.09% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
32 | n/a | Cash | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
33 | n/a | Securities Lending Bnym | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
PBE (INVESCO BIOTECHNOLOGY & GENOME ETF) Sector Allocation
HEALTHCARE
99.90%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%